Diversified Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.2M | Sell |
68,165
-1,956
| -3% | -$421K | 0.27% | 49 |
|
|
2026
Q1 | $15.3M | Buy |
70,121
+8,430
| +14% | +$1.87M | 0.28% | 44 |
|
|
2025
Q4 | $14.1M | Buy |
61,691
+4,615
| +8% | +$1.05M | 0.26% | 45 |
|
|
2025
Q3 | $13.2M | Buy |
57,076
+10,891
| +24% | +$2.22M | 0.26% | 46 |
|
|
2025
Q2 | $8.57M | Sell |
46,185
-1,039
| -2% | -$193K | 0.19% | 70 |
|
|
2025
Q1 | $9.89M | Buy |
47,224
+5,354
| +13% | +$1.04M | 0.24% | 56 |
|
|
2024
Q4 | $7.44M | Buy |
41,870
+1,904
| +5% | +$350K | 0.18% | 68 |
|
|
2024
Q3 | $7.89M | Buy |
39,966
+3,324
| +9% | +$620K | 0.2% | 64 |
|
|
2024
Q2 | $6.28M | Sell |
36,642
-6,375
| -15% | -$1.06M | 0.18% | 68 |
|
|
2024
Q1 | $7.83M | Sell |
43,017
-4,122
| -9% | -$710K | 0.24% | 56 |
|
|
2023
Q4 | $7.31M | Sell |
47,139
-28
| -0.1% | -$4.08K | 0.25% | 55 |
|
|
2023
Q3 | $7.03M | Buy |
47,167
+1,864
| +4% | +$274K | 0.27% | 50 |
|
|
2023
Q2 | $6.1M | Buy |
45,303
+57
| +0.1% | +$8.36K | 0.22% | 56 |
|
|
2023
Q1 | $7.21M | Buy |
45,246
+2,544
| +6% | +$389K | 0.28% | 47 |
|
|
2022
Q4 | $6.9M | Buy |
42,702
+8,569
| +25% | +$1.31M | 0.29% | 45 |
|
|
2022
Q3 | $4.58M | Sell |
34,133
-8,749
| -20% | -$1.26M | 0.21% | 63 |
|
|
2022
Q2 | $6.57M | Buy |
42,882
+7,044
| +20% | +$1.08M | 0.28% | 44 |
|
|
2022
Q1 | $5.81M | Buy |
35,838
+11,347
| +46% | +$1.65M | 0.2% | 61 |
|
|
2021
Q4 | $3.32M | Buy |
24,491
+4,305
| +21% | +$509K | 0.11% | 104 |
|
|
2021
Q3 | $2.18M | Buy |
20,186
+99
| +0.5% | +$11.3K | 0.08% | 130 |
|
|
2021
Q2 | $2.26M | Buy |
20,087
+52
| +0.3% | +$5.86K | 0.08% | 124 |
|
|
2021
Q1 | $2.17M | Buy |
20,035
+96
| +0.5% | +$10.3K | 0.08% | 121 |
|
|
2020
Q4 | $2.14M | Sell |
19,939
-704
| -3% | -$67.7K | 0.09% | 115 |
|
|
2020
Q3 | $1.81M | Buy |
20,643
+285
| +1% | +$26.8K | 0.08% | 121 |
|
|
2020
Q2 | $2M | Buy |
20,358
+5,983
| +42% | +$527K | 0.1% | 101 |
|
|
2020
Q1 | $1.09M | Sell |
14,375
-245
| -2% | -$20.9K | 0.06% | 123 |
|
|
2019
Q4 | $1.29M | Sell |
14,620
-9
| -0.1% | -$747 | 0.06% | 119 |
|
|
2019
Q3 | $1.11M | Sell |
14,629
-45
| -0.3% | -$3.08K | 0.05% | 115 |
|
|
2019
Q2 | $1.07M | Buy |
14,674
+1,998
| +16% | +$157K | 0.05% | 125 |
|
|
2019
Q1 | $1.02M | Sell |
12,676
-53
| -0.4% | -$4.34K | 0.05% | 128 |
|
|
2018
Q4 | $1.17M | Buy |
12,729
+253
| +2% | +$22.2K | 0.07% | 104 |
|
|
2018
Q3 | $1.18M | Sell |
12,476
-9
| -0.1% | -$853 | 0.06% | 112 |
|
|
2018
Q2 | $1.16M | Sell |
12,485
-37
| -0.3% | -$3.61K | 0.07% | 101 |
|
|
2018
Q1 | $1.19M | Sell |
12,522
-444
| -3% | -$48.8K | 0.08% | 99 |
|
|
2017
Q4 | $1.25M | Buy |
12,966
+375
| +3% | +$35.3K | 0.08% | 101 |
|
|
2017
Q3 | $1.12M | Buy |
12,591
+126
| +1% | +$9.59K | 0.09% | 106 |
|
|
2017
Q2 | $904K | Buy |
12,465
+423
| +4% | +$28.4K | 0.07% | 114 |
|
|
2017
Q1 | $785K | Buy |
12,042
+69
| +0.6% | +$4.34K | 0.06% | 119 |
|
|
2016
Q4 | $750K | Buy |
11,973
+209
| +2% | +$12.8K | 0.06% | 116 |
|
|
2016
Q3 | $742K | Buy |
11,764
+29
| +0.2% | +$1.88K | 0.09% | 140 |
|
|
2016
Q2 | $727K | Sell |
11,735
-920
| -7% | -$56.1K | 0.08% | 196 |
|
|
2016
Q1 | $723K | Sell |
12,655
-150
| -1% | -$8.36K | 0.08% | 200 |
|
|
2015
Q4 | $759K | Sell |
12,805
-1,597
| -11% | -$92K | 0.08% | 209 |
|
|
2015
Q3 | $784K | Sell |
14,402
-317
| -2% | -$20.6K | 0.08% | 206 |
|
|
2015
Q2 | $989K | Buy |
14,719
+467
| +3% | +$30.5K | 0.09% | 214 |
|
|
2015
Q1 | $834K | Sell |
14,252
-1,000
| -7% | -$60.4K | 0.07% | 246 |
|
|
2014
Q4 | $998K | Buy |
+15,252
| New | +$962K | 0.09% | 229 |
|
|
2014
Q2 | $769K | Buy |
+13,630
| New | +$715K | 0.06% | 297 |
|
|
2013
Q4 | $334K | Sell |
6,320
-1,590
| -20% | -$78.1K | 0.03% | 386 |
|
|
2013
Q3 | $354K | Hold |
7,910
| – | – | 0.04% | 375 |
|
|
2013
Q2 | $327K | Buy |
+7,910
| New | +$346K | 0.04% | 380 |
|
Other funds holding ABBV
Diversified Trust's ABBV Position: Q2 2026 in Review
Diversified Trust reduced its AbbVie (ABBV) stake by 2.8% in Q2 2026, selling an estimated $421K and leaving 68,165 shares worth $17.2M. The position accounts for 0.27% of the portfolio, ranked #49.
Diversified Trust first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Diversified Trust held 68,165 shares of AbbVie worth $17.2M as of Q2 2026.
- Diversified Trust sold 1,956 AbbVie shares in Q2 2026, an estimated $421K.
- AbbVie made up 0.27% of Diversified Trust's portfolio in Q2 2026, its #49 holding.
- Diversified Trust first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.